logo
  

ANI Pharmaceuticals, Inc. Q3 adjusted earnings Beat Estimates

Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):

-Earnings: -$4.45 million in Q3 vs. $0.43 million in the same period last year.
-EPS: -$0.37 in Q3 vs. $0.04 in the same period last year.
-Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $12.27 million or $1.01 per share for the period.
-Analysts projected $0.70 per share
-Revenue: $52.06 million in Q3 vs. $52.98 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT